Taiwan FDA registration e7b26bd03f0814e18bd340fd9e7b2366
"Siemens" complement C4 reagent set
TW: “西門子”補體C4試劑組
Taiwan·Risk Class 2·RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Jan 24, 2008 – Jan 24, 2028ActiveRegistration details
- Analysis ID
- e7b26bd03f0814e18bd340fd9e7b2366
- Customs Code
- DHA00601894206
Company information
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- Quantitative determination of complement C4 in human serum on the ADVIA automated chemical analysis system.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5240 補體成份免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Jan 24, 2008
- Expiry Date
- Jan 24, 2028
About this record
Access comprehensive regulatory information for "Siemens" complement C4 reagent set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e7b26bd03f0814e18bd340fd9e7b2366 and manufactured by RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices